![]() | Up a level |
Adamson, Douglas, Byrne, Anthony, Porter, Catharine, Blazeby, Jane, Griffiths, Gareth, Nelson, Annmarie, Sewell, Bernadette, Jones, Mari, Svobodova, Martina, Fitzsimmons, Deborah, Nixon, Lisette, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John and Hurt, Christopher
2021.
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet Gastroenterology and Hepatology
6
(4)
, pp. 292-303.
10.1016/S2468-1253(21)00004-2
![]() |
![]() |
Hurt, Chris, Ramaraj, Rajeswari, Farr, Angela, Morgan, Meleri, Williams, Namor, Phillips, Ceri J., Williams, Geraint T., Gardner, Georgina, Porter, Catharine, Sampson, Julian, Hillier, Sharon, Heard, Hayley, Dolwani, Sunil and CONSCOP Clinical Research Consortium,
2019.
Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial.
Lancet Gastroenterology and Hepatology
4
(5)
, pp. 364-375.
10.1016/S2468-1253(19)30035-4
![]() |
|
Prout, Hayley C., Barham, Allan, Bongard, Emily, Tudor-Edwards, Rhiannon, Griffiths, Gareth, Hamilton, Willie, Harrop, Emily, Hood, Kerry, Hurt, Chris N., Nelson, Rosie, Porter, Catherine, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Emma, Tod, Angela, Yeo, Seow Tien, Neal, Richard D. and Nelson, Annmarie 2018. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials 19 , 419. 10.1186/s13063-018-2803-4 |
|
Neal, Richard D., Barham, Allan, Bongard, Emily, Tudor Edwards, Rhiannon, Fitzgibbon, Jim, Griffiths, Gareth, Hamilton, Willie, Hood, Kerenza, Nelson, Annmarie, Parker, David, Porter, Cath, Prout, Hayley, Roberts, Kirsty, Rogers, Trevor, Thomas-Jones, Emma, Tod, Angela, Yeo, Seow Tien and Hurt, Chris N. 2017. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer 116 (3) , pp. 293-302. 10.1038/bjc.2016.414 |
|